Hypoglycemia CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{MAD}}
{{CMG}} {{AE}} {{MAD}}
== Overview ==
== Overview ==
Ultrasound, Computed tomography and MRI can differentiate between insulinoma and islet-cell [[hypertrophy]].
CT scan is currently accepted as the first line of investigation for diagnosing insulinoma. Currently, with the advances in technology, the [[Sensitivity (tests)|sensitivity]] has risen to 80% and 94.4% for [[helical CT scan]] with dual-phase multidetector CT scan. Insulinoma is hypervascular and thus CT shows greater enhancement (hyper-attenuation) than rest of the pancreatic [[parenchyma]]. Cystic and nodular masses with calcification indicates malignant insulinoma. Metastasis can be detected by CT scan.


== CT ==
== CT ==

Revision as of 22:41, 19 September 2017

Hypoglycemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoglycemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoglycemia CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoglycemia CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoglycemia CT

CDC on Hypoglycemia CT

Hypoglycemia CT in the news

Blogs on Hypoglycemia CT

Directions to Hospitals Treating Hypoglycemia

Risk calculators and risk factors for Hypoglycemia CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

CT scan is currently accepted as the first line of investigation for diagnosing insulinoma. Currently, with the advances in technology, the sensitivity has risen to 80% and 94.4% for helical CT scan with dual-phase multidetector CT scan. Insulinoma is hypervascular and thus CT shows greater enhancement (hyper-attenuation) than rest of the pancreatic parenchyma. Cystic and nodular masses with calcification indicates malignant insulinoma. Metastasis can be detected by CT scan.

CT

  • Hypoglycemia caused by endogenous insulin the differential diagnosis includes insulinoma and islet-cell hypertrophy.
  • Ultrasound, Computed tomography and MRI can differentiate between both.[1]
  • A negative imaging study does not exclude insulinoma and patient need more tests.
  • CT shows hyperattenuating on arterial phase so arterial or pancreatic phase imaging may aid in better detection. Some may show calcification.[2]
  • Sensitivity of CT scan for diagnosing insulinoma was 33-64%. With the recent advances in technology and knowledge of rapid contrast-enhanced CT scan in early phase has increased the sentivity to 80%. [1]Most insulinomas are smaller,<1.3 cm (50%) and many of these are non-contour forming. therefore CT scan is less effective in diagnosing them than MRI.[2][3]
  • Abdominal Contrast enhanced CT(CECT) scan may be helpful in the diagnosis of insulinoma. Findings on CT scan suggestive of insulinoma include[1]:
  • Greater degree of enhancement(hyper-attenuation) than parenchyma of the rest of pancreas(as its hypervascular)during the vascular phases of the contrast
  • Atypically can appear hypovascular and hypodense lesions after the administration of contrast, as compared to hyperdense lesions before the administration; cystic masses, and calcified masses(in malignant lesions when they are nodular and discrete)[2][3]
  • CT quality have been improved with techology advances with using dual-phase thin-section multdetector CT having senstivity of 94.4% as compared to 57% for dual-phase multidetector without thin sections and 28.6% with sequential CT.[2][4]
  • It is helpful for detetcting metastasis.
CT showing insulinoma, source: Case courtesy of Dr J. Ray Ballinger, Radiopaedia.org, rID: 23627

References

  1. Noone TC, Hosey J, Firat Z, Semelka RC (2005). "Imaging and localization of islet-cell tumours of the pancreas on CT and MRI". Best Pract Res Clin Endocrinol Metab. 19 (2): 195–211. doi:10.1016/j.beem.2004.11.013. PMID 15763695.
  2. King AD, Ko GT, Yeung VT, Chow CC, Griffith J, Cockram CS (1998). "Dual phase spiral CT in the detection of small insulinomas of the pancreas". Br J Radiol. 71 (841): 20–3. doi:10.1259/bjr.71.841.9534694. PMID 9534694.